A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels.

When new model was compared to other risk factor or risk scores in the validation set ( Table 3 ), AUROCs at each time point were constantly higher in the new model than those for age, ALT, and REACH-B score, although the difference did not reach statistical significance at 3 years for age and at 3 and 6 years for REACH-B.

also in 111,027 other papers